Arcutis Biotherapeutics Inc. (ARQT) Social Stream
ARCUTIS BIOTHERAPEUTICS INC (ARQT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ARQT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 5 | $80 | $48 | $57.2 | $4.05 | 1312.35% |
| 2022-02-03 | 4 | $80 | $35 | $54.2 | $4.05 | 1238.27% |
| 2022-02-24 | 5 | $80 | $35 | $54.2 | $4.05 | 1238.27% |
| 2022-03-02 | 5 | $80 | $37 | $54.6 | $4.05 | 1248.15% |
| 2022-04-07 | 5 | $80 | $37 | $54.4 | $4.05 | 1243.21% |
| 2022-05-10 | 5 | $80 | $36 | $54.2 | $4.05 | 1238.27% |
| 2022-05-23 | 6 | $80 | $36 | $52.666 | $4.05 | 1200.4% |
| 2022-06-07 | 6 | $80 | $39 | $53.166 | $4.05 | 1212.74% |
| 2022-08-01 | 5 | $80 | $39 | $53.5 | $4.05 | 1220.99% |
| 2022-08-02 | 5 | $80 | $45 | $54.5 | $4.05 | 1245.68% |
| 2022-08-19 | 5 | $80 | $45 | $55.333 | $4.05 | 1266.25% |
| 2022-09-07 | 6 | $80 | $45 | $54 | $4.05 | 1233.33% |
| 2022-09-27 | 7 | $80 | $45 | $54.571 | $4.05 | 1247.43% |
| 2022-11-02 | 7 | $80 | $46 | $55.142 | $4.05 | 1261.53% |
| 2022-11-10 | 7 | $80 | $46 | $55.142 | $4.05 | 1261.53% |
| 2023-01-23 | 7 | $80 | $46 | $55.428 | $4.05 | 1268.59% |
| 2023-03-02 | 7 | $80 | $46 | $55.285 | $4.05 | 1265.06% |
| 2023-04-05 | 7 | $80 | $45 | $54.571 | $4.05 | 1247.43% |
| 2023-04-12 | 7 | $80 | $45 | $54.142 | $4.05 | 1236.84% |
| 2023-04-19 | 7 | $80 | $24 | $51 | $4.05 | 1159.26% |
| 2023-04-24 | 7 | $80.001 | $24 | $51 | $4.05 | 1159.26% |
| 2023-05-11 | 7 | $65 | $24 | $48 | $4.05 | 1085.19% |
| 2023-05-26 | 7 | $65 | $24 | $44.857 | $4.05 | 1007.58% |
| 2023-08-08 | 6 | $65 | $24 | $44.571 | $4.05 | 1000.52% |
| 2023-08-10 | 6 | $57 | $22 | $42.142 | $4.05 | 940.54% |
| 2023-10-13 | 6 | $50 | $6 | $35.166 | $4.05 | 768.3% |
| 2023-10-26 | 6 | $50 | $6 | $35.166 | $4.05 | 768.3% |
| 2023-10-27 | 6 | $50 | $4 | $30.714 | $4.05 | 658.37% |
| 2023-11-06 | 6 | $50 | $4 | $26.428 | $4.05 | 552.54% |
| 2023-11-10 | 5 | $38 | $4 | $14.333 | $4.05 | 253.9% |
| 2023-12-21 | 5 | $38 | $4 | $14.5 | $4.05 | 258.02% |
The Trend in the Analyst Price Target
Over the past 41 months, ARQT's average price target has gone down $29.
ARQT reports an average of 464.92% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-23 | 6 | 80 | 46 | 55.428 | 16.32 | 239.63% |
| 2023-03-02 | 7 | 80 | 46 | 55.285 | 15.82 | 249.46% |
| 2023-05-10 | 7 | 65 | 24 | 48.000 | 12.03 | 299% |
| 2023-08-10 | 5 | 57 | 24 | 42.428 | 9.28 | 357.2% |
| 2023-08-10 | 5 | 57 | 22 | 42.142 | 9.28 | 354.12% |
ARQT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 1 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
ARQT's average broker recommendation rating worsened by 0.33 over the prior 42 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, ARCUTIS BIOTHERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 3973.17% of them.
- ARCUTIS BIOTHERAPEUTICS INC's average analyst price target is higher than 3514.6% of stocks in the small market cap category.
- In terms of how ARCUTIS BIOTHERAPEUTICS INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -3075.54% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ARCUTIS BIOTHERAPEUTICS INC's number of analysts covering the stock is higher than 2804.66% of them.
Stocks similar to ARCUTIS BIOTHERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RAPT, TFFP, and APRE.
View All Top Stocks by Price Target
Make investment decisions regarding ARQT using the data that counts. Try POWR Ratings for free.